Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Liposomes Market Growth 2022-2028

  • LP 4795951
  • 102 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Liposomes will have significant change from previous year. According to our (LP Information) latest study, the global Liposomes market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Liposomes market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Liposomes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Liposomes market, reaching US$ million by the year 2028. As for the Europe Liposomes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Liposomes players cover Johnson & Johnson, Gilead Sciences, Pacira, and Sun Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Fungal Infection Therapy

Cancer & Tumor Therapy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Johnson & Johnson

Gilead Sciences

Pacira

Sun Pharmaceutical

Luye Pharma

Sigma-Tau Group

Fudan-Zhangjiang

Teva Pharmaceutical

CSPC

Novartis

Kingond Pharm

Spectrum Pharmaceuticals

Shanghai New Asia

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Liposomes Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Liposomes by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Liposomes by Country/Region, 2017, 2022 & 2028

2.2 Liposomes Segment by Type

2.2.1 Liposomal Doxorubicin

2.2.2 Liposomal Amphoteracin B

2.2.3 Liposomal Paclitaxel

2.2.4 Others

2.3 Liposomes Sales by Type

2.3.1 Global Liposomes Sales Market Share by Type (2017-2022)

2.3.2 Global Liposomes Revenue and Market Share by Type (2017-2022)

2.3.3 Global Liposomes Sale Price by Type (2017-2022)

2.4 Liposomes Segment by Application

2.4.1 Fungal Infection Therapy

2.4.2 Cancer & Tumor Therapy

2.4.3 Others

2.5 Liposomes Sales by Application

2.5.1 Global Liposomes Sale Market Share by Application (2017-2022)

2.5.2 Global Liposomes Revenue and Market Share by Application (2017-2022)

2.5.3 Global Liposomes Sale Price by Application (2017-2022)

3 Global Liposomes by Company

3.1 Global Liposomes Breakdown Data by Company

3.1.1 Global Liposomes Annual Sales by Company (2020-2022)

3.1.2 Global Liposomes Sales Market Share by Company (2020-2022)

3.2 Global Liposomes Annual Revenue by Company (2020-2022)

3.2.1 Global Liposomes Revenue by Company (2020-2022)

3.2.2 Global Liposomes Revenue Market Share by Company (2020-2022)

3.3 Global Liposomes Sale Price by Company

3.4 Key Manufacturers Liposomes Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Liposomes Product Location Distribution

3.4.2 Players Liposomes Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Liposomes by Geographic Region

4.1 World Historic Liposomes Market Size by Geographic Region (2017-2022)

4.1.1 Global Liposomes Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Liposomes Annual Revenue by Geographic Region

4.2 World Historic Liposomes Market Size by Country/Region (2017-2022)

4.2.1 Global Liposomes Annual Sales by Country/Region (2017-2022)

4.2.2 Global Liposomes Annual Revenue by Country/Region

4.3 Americas Liposomes Sales Growth

4.4 APAC Liposomes Sales Growth

4.5 Europe Liposomes Sales Growth

4.6 Middle East & Africa Liposomes Sales Growth

5 Americas

5.1 Americas Liposomes Sales by Country

5.1.1 Americas Liposomes Sales by Country (2017-2022)

5.1.2 Americas Liposomes Revenue by Country (2017-2022)

5.2 Americas Liposomes Sales by Type

5.3 Americas Liposomes Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Liposomes Sales by Region

6.1.1 APAC Liposomes Sales by Region (2017-2022)

6.1.2 APAC Liposomes Revenue by Region (2017-2022)

6.2 APAC Liposomes Sales by Type

6.3 APAC Liposomes Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Liposomes by Country

7.1.1 Europe Liposomes Sales by Country (2017-2022)

7.1.2 Europe Liposomes Revenue by Country (2017-2022)

7.2 Europe Liposomes Sales by Type

7.3 Europe Liposomes Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Liposomes by Country

8.1.1 Middle East & Africa Liposomes Sales by Country (2017-2022)

8.1.2 Middle East & Africa Liposomes Revenue by Country (2017-2022)

8.2 Middle East & Africa Liposomes Sales by Type

8.3 Middle East & Africa Liposomes Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Liposomes

10.3 Manufacturing Process Analysis of Liposomes

10.4 Industry Chain Structure of Liposomes

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Liposomes Distributors

11.3 Liposomes Customer

12 World Forecast Review for Liposomes by Geographic Region

12.1 Global Liposomes Market Size Forecast by Region

12.1.1 Global Liposomes Forecast by Region (2023-2028)

12.1.2 Global Liposomes Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Liposomes Forecast by Type

12.7 Global Liposomes Forecast by Application

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Liposomes Product Offered

13.1.3 Johnson & Johnson Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Gilead Sciences

13.2.1 Gilead Sciences Company Information

13.2.2 Gilead Sciences Liposomes Product Offered

13.2.3 Gilead Sciences Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Gilead Sciences Main Business Overview

13.2.5 Gilead Sciences Latest Developments

13.3 Pacira

13.3.1 Pacira Company Information

13.3.2 Pacira Liposomes Product Offered

13.3.3 Pacira Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pacira Main Business Overview

13.3.5 Pacira Latest Developments

13.4 Sun Pharmaceutical

13.4.1 Sun Pharmaceutical Company Information

13.4.2 Sun Pharmaceutical Liposomes Product Offered

13.4.3 Sun Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sun Pharmaceutical Main Business Overview

13.4.5 Sun Pharmaceutical Latest Developments

13.5 Luye Pharma

13.5.1 Luye Pharma Company Information

13.5.2 Luye Pharma Liposomes Product Offered

13.5.3 Luye Pharma Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Luye Pharma Main Business Overview

13.5.5 Luye Pharma Latest Developments

13.6 Sigma-Tau Group

13.6.1 Sigma-Tau Group Company Information

13.6.2 Sigma-Tau Group Liposomes Product Offered

13.6.3 Sigma-Tau Group Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sigma-Tau Group Main Business Overview

13.6.5 Sigma-Tau Group Latest Developments

13.7 Fudan-Zhangjiang

13.7.1 Fudan-Zhangjiang Company Information

13.7.2 Fudan-Zhangjiang Liposomes Product Offered

13.7.3 Fudan-Zhangjiang Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Fudan-Zhangjiang Main Business Overview

13.7.5 Fudan-Zhangjiang Latest Developments

13.8 Teva Pharmaceutical

13.8.1 Teva Pharmaceutical Company Information

13.8.2 Teva Pharmaceutical Liposomes Product Offered

13.8.3 Teva Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Teva Pharmaceutical Main Business Overview

13.8.5 Teva Pharmaceutical Latest Developments

13.9 CSPC

13.9.1 CSPC Company Information

13.9.2 CSPC Liposomes Product Offered

13.9.3 CSPC Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 CSPC Main Business Overview

13.9.5 CSPC Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis Liposomes Product Offered

13.10.3 Novartis Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 Kingond Pharm

13.11.1 Kingond Pharm Company Information

13.11.2 Kingond Pharm Liposomes Product Offered

13.11.3 Kingond Pharm Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Kingond Pharm Main Business Overview

13.11.5 Kingond Pharm Latest Developments

13.12 Spectrum Pharmaceuticals

13.12.1 Spectrum Pharmaceuticals Company Information

13.12.2 Spectrum Pharmaceuticals Liposomes Product Offered

13.12.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Spectrum Pharmaceuticals Main Business Overview

13.12.5 Spectrum Pharmaceuticals Latest Developments

13.13 Shanghai New Asia

13.13.1 Shanghai New Asia Company Information

13.13.2 Shanghai New Asia Liposomes Product Offered

13.13.3 Shanghai New Asia Liposomes Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai New Asia Main Business Overview

13.13.5 Shanghai New Asia Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Liposomes Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Liposomes Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Liposomal Doxorubicin

Table 4. Major Players of Liposomal Amphoteracin B

Table 5. Major Players of Liposomal Paclitaxel

Table 6. Major Players of Others

Table 7. Global Liposomes Sales by Type (2017-2022) & (K Units)

Table 8. Global Liposomes Sales Market Share by Type (2017-2022)

Table 9. Global Liposomes Revenue by Type (2017-2022) & ($ million)

Table 10. Global Liposomes Revenue Market Share by Type (2017-2022)

Table 11. Global Liposomes Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Liposomes Sales by Application (2017-2022) & (K Units)

Table 13. Global Liposomes Sales Market Share by Application (2017-2022)

Table 14. Global Liposomes Revenue by Application (2017-2022)

Table 15. Global Liposomes Revenue Market Share by Application (2017-2022)

Table 16. Global Liposomes Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Liposomes Sales by Company (2020-2022) & (K Units)

Table 18. Global Liposomes Sales Market Share by Company (2020-2022)

Table 19. Global Liposomes Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Liposomes Revenue Market Share by Company (2020-2022)

Table 21. Global Liposomes Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Liposomes Producing Area Distribution and Sales Area

Table 23. Players Liposomes Products Offered

Table 24. Liposomes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Liposomes Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Liposomes Sales Market Share Geographic Region (2017-2022)

Table 29. Global Liposomes Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Liposomes Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Liposomes Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Liposomes Sales Market Share by Country/Region (2017-2022)

Table 33. Global Liposomes Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Liposomes Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Liposomes Sales by Country (2017-2022) & (K Units)

Table 36. Americas Liposomes Sales Market Share by Country (2017-2022)

Table 37. Americas Liposomes Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Liposomes Revenue Market Share by Country (2017-2022)

Table 39. Americas Liposomes Sales by Type (2017-2022) & (K Units)

Table 40. Americas Liposomes Sales Market Share by Type (2017-2022)

Table 41. Americas Liposomes Sales by Application (2017-2022) & (K Units)

Table 42. Americas Liposomes Sales Market Share by Application (2017-2022)

Table 43. APAC Liposomes Sales by Region (2017-2022) & (K Units)

Table 44. APAC Liposomes Sales Market Share by Region (2017-2022)

Table 45. APAC Liposomes Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Liposomes Revenue Market Share by Region (2017-2022)

Table 47. APAC Liposomes Sales by Type (2017-2022) & (K Units)

Table 48. APAC Liposomes Sales Market Share by Type (2017-2022)

Table 49. APAC Liposomes Sales by Application (2017-2022) & (K Units)

Table 50. APAC Liposomes Sales Market Share by Application (2017-2022)

Table 51. Europe Liposomes Sales by Country (2017-2022) & (K Units)

Table 52. Europe Liposomes Sales Market Share by Country (2017-2022)

Table 53. Europe Liposomes Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Liposomes Revenue Market Share by Country (2017-2022)

Table 55. Europe Liposomes Sales by Type (2017-2022) & (K Units)

Table 56. Europe Liposomes Sales Market Share by Type (2017-2022)

Table 57. Europe Liposomes Sales by Application (2017-2022) & (K Units)

Table 58. Europe Liposomes Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Liposomes Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Liposomes Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Liposomes Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Liposomes Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Liposomes Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Liposomes Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Liposomes Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Liposomes Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Liposomes

Table 68. Key Market Challenges & Risks of Liposomes

Table 69. Key Industry Trends of Liposomes

Table 70. Liposomes Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Liposomes Distributors List

Table 73. Liposomes Customer List

Table 74. Global Liposomes Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Liposomes Sales Market Forecast by Region

Table 76. Global Liposomes Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Liposomes Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Liposomes Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Liposomes Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Liposomes Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Liposomes Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Liposomes Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Liposomes Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Liposomes Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Liposomes Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Liposomes Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Liposomes Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Liposomes Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Liposomes Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Liposomes Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Liposomes Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Liposomes Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Liposomes Revenue Market Share Forecast by Application (2023-2028)

Table 94. Johnson & Johnson Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 95. Johnson & Johnson Liposomes Product Offered

Table 96. Johnson & Johnson Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Johnson & Johnson Main Business

Table 98. Johnson & Johnson Latest Developments

Table 99. Gilead Sciences Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 100. Gilead Sciences Liposomes Product Offered

Table 101. Gilead Sciences Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Gilead Sciences Main Business

Table 103. Gilead Sciences Latest Developments

Table 104. Pacira Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 105. Pacira Liposomes Product Offered

Table 106. Pacira Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Pacira Main Business

Table 108. Pacira Latest Developments

Table 109. Sun Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 110. Sun Pharmaceutical Liposomes Product Offered

Table 111. Sun Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Sun Pharmaceutical Main Business

Table 113. Sun Pharmaceutical Latest Developments

Table 114. Luye Pharma Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 115. Luye Pharma Liposomes Product Offered

Table 116. Luye Pharma Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Luye Pharma Main Business

Table 118. Luye Pharma Latest Developments

Table 119. Sigma-Tau Group Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 120. Sigma-Tau Group Liposomes Product Offered

Table 121. Sigma-Tau Group Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Sigma-Tau Group Main Business

Table 123. Sigma-Tau Group Latest Developments

Table 124. Fudan-Zhangjiang Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 125. Fudan-Zhangjiang Liposomes Product Offered

Table 126. Fudan-Zhangjiang Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Fudan-Zhangjiang Main Business

Table 128. Fudan-Zhangjiang Latest Developments

Table 129. Teva Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 130. Teva Pharmaceutical Liposomes Product Offered

Table 131. Teva Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Teva Pharmaceutical Main Business

Table 133. Teva Pharmaceutical Latest Developments

Table 134. CSPC Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 135. CSPC Liposomes Product Offered

Table 136. CSPC Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. CSPC Main Business

Table 138. CSPC Latest Developments

Table 139. Novartis Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 140. Novartis Liposomes Product Offered

Table 141. Novartis Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Novartis Main Business

Table 143. Novartis Latest Developments

Table 144. Kingond Pharm Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 145. Kingond Pharm Liposomes Product Offered

Table 146. Kingond Pharm Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Kingond Pharm Main Business

Table 148. Kingond Pharm Latest Developments

Table 149. Spectrum Pharmaceuticals Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 150. Spectrum Pharmaceuticals Liposomes Product Offered

Table 151. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Spectrum Pharmaceuticals Main Business

Table 153. Spectrum Pharmaceuticals Latest Developments

Table 154. Shanghai New Asia Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors

Table 155. Shanghai New Asia Liposomes Product Offered

Table 156. Shanghai New Asia Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Shanghai New Asia Main Business

Table 158. Shanghai New Asia Latest Developments

List of Figures

Figure 1. Picture of Liposomes

Figure 2. Liposomes Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Liposomes Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Liposomes Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Liposomes Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Liposomal Doxorubicin

Figure 10. Product Picture of Liposomal Amphoteracin B

Figure 11. Product Picture of Liposomal Paclitaxel

Figure 12. Product Picture of Others

Figure 13. Global Liposomes Sales Market Share by Type in 2021

Figure 14. Global Liposomes Revenue Market Share by Type (2017-2022)

Figure 15. Liposomes Consumed in Fungal Infection Therapy

Figure 16. Global Liposomes Market: Fungal Infection Therapy (2017-2022) & (K Units)

Figure 17. Liposomes Consumed in Cancer & Tumor Therapy

Figure 18. Global Liposomes Market: Cancer & Tumor Therapy (2017-2022) & (K Units)

Figure 19. Liposomes Consumed in Others

Figure 20. Global Liposomes Market: Others (2017-2022) & (K Units)

Figure 21. Global Liposomes Sales Market Share by Application (2017-2022)

Figure 22. Global Liposomes Revenue Market Share by Application in 2021

Figure 23. Liposomes Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Liposomes Revenue Market Share by Company in 2021

Figure 25. Global Liposomes Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Liposomes Revenue Market Share by Geographic Region in 2021

Figure 27. Global Liposomes Sales Market Share by Region (2017-2022)

Figure 28. Global Liposomes Revenue Market Share by Country/Region in 2021

Figure 29. Americas Liposomes Sales 2017-2022 (K Units)

Figure 30. Americas Liposomes Revenue 2017-2022 ($ Millions)

Figure 31. APAC Liposomes Sales 2017-2022 (K Units)

Figure 32. APAC Liposomes Revenue 2017-2022 ($ Millions)

Figure 33. Europe Liposomes Sales 2017-2022 (K Units)

Figure 34. Europe Liposomes Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Liposomes Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Liposomes Revenue 2017-2022 ($ Millions)

Figure 37. Americas Liposomes Sales Market Share by Country in 2021

Figure 38. Americas Liposomes Revenue Market Share by Country in 2021

Figure 39. United States Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Liposomes Sales Market Share by Region in 2021

Figure 44. APAC Liposomes Revenue Market Share by Regions in 2021

Figure 45. China Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Liposomes Sales Market Share by Country in 2021

Figure 52. Europe Liposomes Revenue Market Share by Country in 2021

Figure 53. Germany Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Liposomes Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Liposomes Revenue Market Share by Country in 2021

Figure 60. Egypt Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Liposomes Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Liposomes in 2021

Figure 66. Manufacturing Process Analysis of Liposomes

Figure 67. Industry Chain Structure of Liposomes

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390